This report is just out today from the IQVIA Institute, in collaboration with Translucent Datalab and IE University.

I hope you will take time to download and share our latest report on The Use of Medicines in the U.S. 2023.

Today the IQVIA Institute published our annual report on Global Oncology Trends 2023. Download below.

New report out today from the IQVIA Institute with interesting findings on collaborations between #patient orgs and #lifesciences.

Learn more about biosimilar development in Europe in this new report from the IQVIA Institute.

Discover the findings in this new report from the IQVIA Institute published today. #drugs #drugshortages

Just out today from the IQVIA Institute: Research brief looking at global adult vaccination through lens of five cities.

Just published today: IQVIA Institute report on the value of Radioligand Therapy as a treatment for certain cancers.

Check out my latest article: Outlook for 2024: 7 Indicators of Progress in the Life Sciences Sector linkedin.com/pulse/outlook-… via LinkedIn

See what's in our latest report, just released today: The Global Use of Medicines 2024.

Sharing the latest report from the IQVIA Institute, published today.

Latest from IQVIA Institute: Research brief looks at data and context on net drug spending for the first set of drugs selected for negotiations by the U.S. Centers for Medicare & Medicaid Services - including impact on patient out-of-pocket costs.

Latest report from the IQVIA Institute on access to treatments across Europe, Japan, and the U.S. Download to read the findings.

What is happening in #digitalhealth today and how has it changed over the last few years? Download our newest report to find out.

What is the IQVIA Institute's view of 10 indicators of progress for the #lifesciences sector in 2025? Download our research brief to learn more.

Our latest report looks closely at the 'biosimilar void.' Download to learn more.

Learn more about barriers within the RLT patient referral journey in our latest report.

See our new report to learn about the #IRA's #Medicare Drug Price Negotiation Program and how it will impact U.S. drug pricing policy.

Our latest examines state-level research on pharmacist vaccination authority policies and analyzes state-level adult vaccination rates for the RSV, pneumococcal, and shingles vaccines. Read more.